Our approach to investing
We invest across a spectrum of T1D approaches, including companies also working on adjacent diseases and “platform” companies with approaches applicable to T1D.
Other investment considerations
Process
All investment opportunities are reviewed swiftly on a rolling basis in partnership with JDRF to assure appropriate alignment in strategy. Everything is strictly confidential.
Diligence
We follow industry standards generally accepted within venture capital.
Technology
We do not differentiate in the kind of technology that we invest in, so long as it’s transformational and T1D-focused.
R&D
We’re stage agnostic and invest in discovery through clinical stage assets.
Financing Structure
We consider traditional and novel investment structures.
If you’d like to know more about our investing guidelines or want to talk to us about contributing, you can contact us here.